Canakinumab Subcutaneous and Glucagon Injection (Low Blood Sugar)
Determining the interaction of Canakinumab Subcutaneous and Glucagon Injection (Low Blood Sugar) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: glucagon
Brand name: Glucagen, GlucaGen HypoKit, Glucagon Emergency Kit for Low Blood Sugar, Gvoke HypoPen, Gvoke PFS, Baqsimi
Synonyms: Glucagon (injection), Glucagon
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Glucagon Nasal Spray
- Canakinumab Subcutaneous-Glucarpidase
- Canakinumab Subcutaneous-Glucarpidase Intravenous
- Canakinumab Subcutaneous-Glucodex 100 G
- Canakinumab Subcutaneous-Glucodex 50 G
- Canakinumab Subcutaneous-Glucodex 75 G
- Glucagon Injection (Low Blood Sugar)-Canasa
- Glucagon Injection (Low Blood Sugar)-Canasa Pac rectal
- Glucagon Injection (Low Blood Sugar)-Canasa rectal
- Glucagon Injection (Low Blood Sugar)-Cancidas
- Glucagon Injection (Low Blood Sugar)-Candesartan
- Glucagon Injection (Low Blood Sugar)-Candesartan and Hydrochlorothiazide